Abbott releases cybersecurity, battery update for high-voltage implantable cardiac devices

Abbott (NYSE:ABT) today announced a firmware upgrade for its high-voltage implantable cardiac devices looking to shore up cybersecurity and improve battery performance. The company stated that while the update is intended to improve cybersecurity through an additional layer of protection against unauthorized device access, it has not received any reports that any of its devices have been exploited remotely. Abbott also said that it has not identified any new vulnerabilities in its cardiac device portfolio. The newly released firmware upgrade includes an enhanced device-based battery performance alert, Abbott said, which aims to improve battery performance management with certain implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators. The battery update will allow for the monitoring of abnormal battery behavior and will vibrate to alert patients if abnormal behavior is detected. Abbott said the capability was previously limited to its Merlin.net remote monitoring systems. Abbott began the series of updates last year with a focus on pacemaker devices it acquired when it paid $25 billion for St. Jude Medical. The initial improvements came after St. Jude warned in late 2016 of battery issues that could disable high-voltage cardiac rhythm management devices, with two deaths reported in relation to the issue. Those warnings followed a short-seller-fueled scandal about alleged cybersecurity vulnerabilities in the St. Jude devices. Short-selli...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Cardiac Assist Devices Abbott Source Type: news